The Encino Hospital Medical Center is a hospital in Encino, California. The hospital's ownership changed in June 2008 when Tenet Healthcare sold it to the current owner, Prime Healthcare Services. Previously, the hospital was one of the campuses of the Encino-Tarzana Regional Medical Center.

There are 150 beds in Encino Hospital Medical Center.

During the past decade, Encino Hospital Medical Center conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Encino Hospital Medical Center" are "Nonalcoholic Fatty Liver Disease" (1 trials), "Nonalcoholic Steatohepatitis With Liver Fibrosis" (1 trials) and "Schizophrenia" (1 trials). Many other conditions were trialed in "Encino Hospital Medical Center" in a lesser frequency.

Most popular intervention types in "Encino Hospital Medical Center" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "BI 425809" (1 trials), "PF-05221304" (1 trials) and "PF-06865571" (1 trials). Other intervention names were less common.

The vast majority of trials in "Encino Hospital Medical Center" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Encino Hospital Medical Center". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Encino Hospital Medical Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Encino Hospital Medical Center, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".